Evidence map›Paper›PMID 32514432›Full record

ReviewJGH open : an open access journal of gastroenterology and hepatology2020

COVID-19 and its effects on the digestive system and endoscopy practice.

Enrik John T Aguila, Ian Homer Y Cua, Joseph Erwin L Dumagpi, Carlos Paolo D Francisco, Nikko Theodore V Raymundo, Marianne Linley L Sy-Janairo, Patricia Anne I Cabral-Prodigalidad, Marie Antoinette Dc Lontok

Abstract readReview
In one paragraph

Review in JGH open : an open access journal of gastroenterology and hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. COVID, the Gut, and Nutritional Implications.Current surgery reports · 2023
    Review
  6. Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic.Journal of the Canadian Association of Gastroenterology · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. The radiological findings of COVID-19Turkish journal of medical sciences · 2021
    Review
  13. Review
  14. Article
  15. Endoscopy mitigation strategy with telemedicine and low-cost device use for COVID-19 prevention: A fourth-level Colombian center experience.Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology · 2021
    Article
  16. COVID-19 in Gastroenterology Departments: The Impact of the First Wave.GE Portuguese journal of gastroenterology · 2021
    Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Enrik John T AguilaInstitute of Digestive and Liver Diseases St. Luke's Medical Center - Global City Philippines.ORCID https://orcid.org/0000-0003-3440-2406
Ian Homer Y CuaInstitute of Digestive and Liver Diseases St. Luke's Medical Center - Global City Philippines.
Joseph Erwin L DumagpiInstitute of Digestive and Liver Diseases St. Luke's Medical Center - Global City Philippines.
Carlos Paolo D FranciscoInstitute of Digestive and Liver Diseases St. Luke's Medical Center - Global City Philippines.
Nikko Theodore V RaymundoInstitute of Digestive and Liver Diseases St. Luke's Medical Center - Global City Philippines.
Marianne Linley L Sy-JanairoInstitute of Digestive and Liver Diseases St. Luke's Medical Center - Global City Philippines.
Patricia Anne I Cabral-ProdigalidadInstitute of Digestive and Liver Diseases St. Luke's Medical Center - Global City Philippines.
Marie Antoinette Dc LontokInstitute of Digestive and Liver Diseases St. Luke's Medical Center - Global City Philippines.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Coronavirus Disease 2019 (COVID-19) is a respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has been classified as a pandemic by the World Health Organization in March 2020. Several studies have demonstrated that the gastrointestinal (GI) tract is also a potential route. As the pandemic is continuously evolving, and more data are made available, this article highlights the best evidence and practices regarding the effects of the SARS-CoV-2 virus relevant to GI practice. Published clinical studies have supported that SARS-CoV-2 affects the GI tract and the liver. The largest published dataset comprised of 4243 patients and showed a pooled prevalence of GI symptoms at 17.6%. GI symptoms varied and usually preceded pulmonary symptoms by 1-2 days. These include anorexia (26.8%), nausea and vomiting (10.2%), diarrhea (12.5%), and abdominal pain (9.2%). Incidence of liver injury ranges from 15 to 53%. Evidence shows that the severity of COVID-19 infection is compounded by its effects on nutrition, most especially for the critically ill. As such, nutrition societies have recommended optimization of oral diets and oral nutritional supplements followed by early enteral nutrition if nutritional targets are not met, and parenteral nutrition in the distal end of the spectrum. In addition to possible fecal-oral transmission, GI endoscopy procedures, which are considered to be aerosol-generating procedures, contribute to increased risk to GI health-care professionals. Infection prevention measures and guidelines are essential in protecting both patients and personnel.

Indexed as

COVID‐19endoscopygastroenterologylivernutrition

Identifiers

PMID32514432
PMCPMC7273707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.